Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20250410001Not yet recruiting
Trial of capecitabine, sponsored by N/A. Primary endpoint: Development of predictive risk score. Planned start Apr 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20250410001.